BCL2 and neuroblastoma: As the majority of neuroblastoma tumors is dependent on high BCL2 expression levels for survival, we evaluated the effects of combined venetoclax/idasanutlin treatment on cell viability and apoptosis in neuroblastoma cell lines with high BCL2 expression levels.